EMD-50503

Single-particle
2.84 Å
EMD-50503
3D View Gallery
Deposition: 31/05/2024
Map released: 14/08/2024
Last modified: 02/07/2025
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-50503

Archive Files (Depositor)

Primary 3D volume (map.gz) Half-map 1 Half-map 2 (map.gz) Experimental metadata (xml) Experimental metadata (cif.gz)

Validation (wwPDB)

Map-only validation report (pdf.gz) Map-9fjk summary report (pdf.gz) Map-9fjk FULL report (pdf.gz)

EMDB Annotations

EMICSS entry mapping (xml)

EMDB Files

VA raw map (map) VA resolution mask (mrc)

Omicron BA.1 Spike protein with neutralizing NTD specific mAb K501SP6

EMD-50503

Single-particle
2.84 Å
EMD-50503
3D View Gallery
Deposition: 31/05/2024
Map released: 14/08/2024
Last modified: 02/07/2025
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Homo sapiens, Severe acute respiratory syndrome coronavirus 2, Enterobacteria phage T4
Sample: Alphacoronavirus
Fitted models: 9fjk

Deposition Authors: Bjoernsson KH , Walker MR , Raghavan SSR , Ward AB , Barfod LK
Broadly potent spike-specific human monoclonal antibodies inhibit SARS-CoV-2 Omicron sub-lineages.
Walker MR , Underwood A, Bjornsson KH, Raghavan SSR , Bassi MR, Binderup A , Pham LV, Ramirez S , Pinholt M, Dagil R , Knudsen AS, Idorn M , Soegaard M, Wang K , Ward AB , Salanti A , Bukh J , Barfod L
(2024) Commun Biol , 7 , 1239 - 1239
PUBMED: 39354108
DOI: doi:10.1038/s42003-024-06951-7
ISSN: 2399-3642
Grant Support: